4/A
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-18-064381
Options or other derivatives
- Director acquired 1,468 shares (other)
From the SEC's structured data for this filing
Trades in this filing
BioLexis Pte Ltd. · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2018-09-30 | Other acquisition : show line 1 in the form Series A-1 Convertible Preferred Stock | +1,468 | 221,937 | 60,203 | D |
Loading xslF345X03/doc4a.xml…